key: cord-0964489-e8npurjc authors: Antwi‐Amoabeng, Daniel; Beutler, Bryce D.; Singh, Sahajpreet; Taha, Moutaz; Ghuman, Jasmine; Hanfy, Ahmed; Manasewitsch, Nicholas T.; Ulanja, Mark B.; Ghuman, Joban; Awad, Munadel; Gullapalli, Nageshwara; Gbadebo, T. David title: Association between electrocardiographic features and mortality in COVID‐19 patients date: 2021-03-19 journal: Ann Noninvasive Electrocardiol DOI: 10.1111/anec.12833 sha: fc1c0033aaf85a6ffb302efb35b37cf2c0341eff doc_id: 964489 cord_uid: e8npurjc BACKGROUND: Cardiovascular events have been reported in the setting of coronavirus disease‐19 (COVID‐19). It has been hypothesized that systemic inflammation may aggravate arrhythmias or trigger new‐onset conduction abnormalities. However, the specific type and distribution of electrocardiographic disturbances in COVID‐19 as well as their influence on mortality remain to be fully characterized. METHODS: Electrocardiograms (ECGs) were obtained from 186 COVID‐19‐positive patients at a large tertiary care hospital in Northern Nevada. The following arrhythmias were identified by cardiologists: sinus bradycardia, sinus tachycardia, atrial fibrillation (A‐Fib), atrial flutter, multifocal atrial tachycardia (MAT), premature atrial contraction (PAC), premature ventricular contraction (PVC), atrioventricular block (AVB), and right bundle branch block (RBBB). The mean PR interval, QRS duration, and corrected QT interval were documented. Fisher's exact test was used to compare the ECG features of patients who died during the hospitalization with those who survived. The influence of ECG features on mortality was assessed with multivariable logistic regression analysis. RESULTS: A‐Fib, atrial flutter, and ST‐segment depression were predictive of mortality. In addition, the mean ventricular rate was higher among patients who died as compared to those who survived. The use of therapeutic anticoagulation was associated with reduced odds of death; however, this association did not reach statistical significance. CONCLUSION: The underlying pathogenesis of COVID‐19‐associated arrhythmias remains to be established, but we postulate that systemic inflammation and/or hypoxia may induce potentially lethal conduction abnormalities in affected individuals. Longitudinal studies are warranted to evaluate the risk factors, pathogenesis, and management of COVID‐19‐associated cardiac arrhythmias. AtleastoneECGwasobtainedforallpatientsincludedinthestudy. Approximatelyhalfofthepatientsinthecohort ( The frequency distribution of ECG rhythms before and after Atotalof32patients(17.2%)diedduringthehospitalization.A-Fib, atrialflutter,andST-segmentdepressionwerepredictiveofmortality(Table2).Inaddition,themeanventricularratewashigheramong patients who died as compared to those who survived (Figure 2 ). Theuseoftherapeuticanticoagulationwasassociatedwithreduced odds of death; however, this association did not reach statistical significance.Nootherstatisticallysignificantassociationsbetween ECGchangesandmortalitywereidentified. patients (Ledford,2020) .Furtherstudiesareneededtoinvestigate theeffectofcorticosteroidsonarrhythmiaburdeninpatientswith COVID-19. In addition to A-Fib, ST-segment depression was predictive of mortality in our cohort of COVID-19 patients. ST-segment depression is a non-specific indicator of myocardial ischemia and is commonly observed in myocarditis, hypoxia, and acute posterior myocardial infarction. Non-cardiac causes of ST-segment depression include pulmonary embolism, pneumothorax, and sepsis. The underlyingcauseofST-segmentdepressioninCOVID-19isvariable. Myocarditis represents a common and potentially lethal disease manifestation . COVID-19-associated acute myocardial infarction has also been reported . There aremyriadpotentialcausesofmyocardialischemiainthesettingof overwhelminginfection.WepostulatethatST-segmentdepression represents a surrogate marker for severe systemic inflammation, whichisthoughttobeahallmarkofCOVID-19. The aim of the study was to evaluate ECG manifestations of COVID-19anddeterminewhich,ifany,wereassociatedwithanincreasedriskofmortality. arrhythmias has the potential to improve patient outcomes worldwide. Thestudyprotocolandimplementationweredeemedexemptfrom full review by the Institutional Review Board of the University of Nevada,RenoSchoolofMedicine.Thestudywasconductedinaccordance with institutional regulations and guidelines. tionships with industry. Dataareavailablefromtheauthorsuponreasonablerequest. Daniel Antwi-Amoabeng https://orcid. Abbreviations:A-Fib,atrialfibrillation;A-Flutter,atrialflutter;PAC, Premature atrial contraction. Electrocardiographic features of patients with COVID-19 pneumonia GlobalCOVID-19 C-reactiveproteinelevationinpatients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation AtrialarrhythmiasinCOVID-19 patients Roleofinflammation in atrial fibrillation pathophysiology and management CardiacinvolvementofCOVID-19: Lookingforwardtonoveldiscoveriesandclinicallyvaluableevidence Frequencyofcardiacabnormalities inahalfmillionadults Coronavirus breakthrough: Dexamethasone is first drug shown to save lives Incidence andprognosticimpactofnew-onsetatrialfibrillationinpatientswith septicshock:Aprospectiveobservationalstudy Clinicalcharacteristicsof138hospitalizedpatientswith2019novel coronavirus-infected pneumonia in Wuhan How to cite this article:Antwi-AmoabengD,BeutlerBD, SinghS,etal.Associationbetweenelectrocardiographic featuresandmortalityinCOVID-19patients